Product
AI AGENTS
INTELLIGENCE SUITE
API, MCP & INTEGRATION
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
Patsnap Eureka Platform
IP Search Agents
IP Drafting Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
Materials Agents
SEP Agents
Patsnap Eureka Desktop
BetaAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisProfessional Services
Open Platform
Developer Center
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Free tools
NEWWebinars & Training
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Already have an account? Log In
To start using Patsnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Gefurulimab and AstraZeneca's C5 complement inhibitor enter Phase II/III in myasthenia gravis. How do they compare to efgartigimod and ravulizumab?
Article | Report Explore the 2026 nanocellulose composite materials landscape for packaging and structural applications — patent trends, key players, and innovation intelligence.
Article | Report AEMWE patent and literature landscape 2026: membrane chemistry, non-PGM catalysts, scale-up milestones, and strategic IP white space for green hydrogen.
Article | Report Giredestrant (GDC-9545) enters Phase III in early HR+ breast cancer via Roche's evERA trial. Analyse the oral SERD competitive landscape: imlunestrant, camizestrant, elacestrant & more.
Article | Report How AI is transforming systematic literature review for technology platform development — faster screening, smarter synthesis, and patent-aware R&D workflows.
Article | Report Explore the 2026 copper alloy materials landscape for EV motor windings and power connectors. Key IP spaces, technology gaps, and dominant material strategies.
Article | Report A deep analysis of edge AI inference accelerator technology in 2026: dedicated silicon, FPGA, PIM architectures, NAS, and distributed inference across 80+ patent and literature records.
Article | Report Fenebrutinib vs. tolebrutinib: how CNS-penetrant BTK inhibitors target smoldering lesions and microglia in progressive MS. Phase III data signals analysed.
Article | Report The 2026 nickel superalloy landscape for gas turbine blades and additive manufacturing: key data sources, research gaps, and how to retrieve patent intelligence.
Article | Report TGA vs DSC for polymer degradation: understand which thermal analysis technique reveals mass loss, heat flow, or transition data—and when to use both together.
Article | Report Monopile foundations dominate 80% of offshore wind capacity. Explore the 2026 technology landscape: PISA models, TP-less designs, XXL monopiles, and key patents.
Article | Report Explore the key technical barriers to cost-competitive direct lithium extraction (DLE) from geothermal brine, from ion selectivity to scaling challenges.
Article | Report Dostarlimab (Jemperli) PD-1 inhibitor Phase III expansion in dMMR endometrial and colorectal cancer: GSK's biomarker-driven immunotherapy strategy explained.
Article | Report Titanium alloy patent landscape 2026: aerospace lightweighting and medical implants. Key alloy systems, IPC codes, assignees, and how to build a rigorous IP dataset.
Article | Report Explore the 2026 thermoelectric materials landscape: Bi₂Te₃, PbTe, and Half-Heusler alloys for waste heat recovery. Patent trends, ZT advances, and IP intelligence.